With a provision of QPPV, Medical Advisor and other pharmacovigilance personnel services, CRO Biomapas overtakes all or part of Marketing Authorisation Holder’s obligations for the safety surveillance of their medicinal products:
- Adverse Drug Reaction management;
- MedDRA coding and medical assessment of safety information;
- Electronic reporting to EMEA and national competent authorities;
- Pharmacovigilance database;
- Global and local literature and databases screening;
- Compilation, review and submission of Periodic Safety Update Reports;
- Overall overview of medicinal product’s safety profile, risk-benefit balance assessment;
- Risk management;
- Legislative compliance and quality control.
With an experience in Lithuania, Latvia and Estonia, CRO Biomapas can provide services of full pharmacovigilance system or can act as local safety representatives.